Well today signifies the end of the 26 week blind period for the Phase IIb trials, to say I'm excited for the results is an understatement We shall hear very shortly how the past decade of research has lead to this point I originally bought into this company on a whim as a family friend was diagnosed with Parkinson's, with the goal to follow the research and progress, and hopefully soon we can offer an option for an improved outlook on life for her Cheers all
LCT Price at posting:
24.5¢ Sentiment: Buy Disclosure: Held
